Allermi secures $3.5m in seed funding to meet growing demand for customized approach to allergy symptoms

San francisco--(business wire)--allermi, a direct-to-consumer telehealth service providing a customized approach to allergy relief, today announced a $3.5m seed round to continue its mission to deliver a personalized solution to allergy care. the round was led by nelstone ventures, who twice funded apostrophe - a direct-to-consumer telehealth service providing customized skincare solutions - and helped lead their nine figure sale to hims & hers (nyse: hims).
HIMS Ratings Summary
HIMS Quant Ranking